BioVie Inc. Warrant (BIVIW)
Stock · NASDAQ · Health Care
$0.2301as of 10/16/2026
Price chart
Active signals
Resistance level
$0.332125
Industry
Biotechnology: Pharmaceutical Preparations
About BIVIW
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. It also develops Bezisterim, an investig…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 13
Fundamentals
- 1-day range
- $0.2483$0.2637
- Market cap
- $1.06M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
52-week range
$0.13$0.79
BioVie Inc. Warrant Competitors
Chosen by industry and closest market cap.
- BIVIWBioVie Inc. Warrant$0.2301▼ 7.96%Market cap $1.06MP/E —$0.13$0.79
- BDRXBiodexa Pharmaceuticals plc American Depositary Shs$0.456▲ 5.80%Market cap $1.10MP/E —$0.3371$44.7
- MTNBMatinas Biopharma Holdings Inc. Common Stock$2.37▼ 2.07%Market cap $1.72MP/E —$2.26$28.95
- BFRIWBiofrontera Inc. Warrants$0.0052▼ 7.14%Market cap $357.2KP/E —$0.0052$0.1484
- CMNDClearmind Medicine Inc. Common Shares$6.26▼ 2.49%Market cap $1.78MP/E —$5.25$3,840
- CINGWCingulate Inc. Warrants$0.01▲ 14.94%Market cap $133.3KP/E —$0.0026$0.12
- BFRGWBullfrog AI Holdings Inc. Warrants$0.13▲ 25.85%Market cap $2.04MP/E —$0.0751$0.6488
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BIVIW BioVie Inc. Warrant | $1.06M | — | $0.2301 | ▼ 7.96% | $0.13$0.79 |
| BDRX Biodexa Pharmaceuticals plc American Depositary Shs | $1.10M | — | $0.456 | ▲ 5.80% | $0.3371$44.7 |
| MTNB Matinas Biopharma Holdings Inc. Common Stock | $1.72M | — | $2.37 | ▼ 2.07% | $2.26$28.95 |
| BFRIW Biofrontera Inc. Warrants | $357.2K | — | $0.0052 | ▼ 7.14% | $0.0052$0.1484 |
| CMND Clearmind Medicine Inc. Common Shares | $1.78M | — | $6.26 | ▼ 2.49% | $5.25$3,840 |
| CINGW Cingulate Inc. Warrants | $133.3K | — | $0.01 | ▲ 14.94% | $0.0026$0.12 |
| BFRGW Bullfrog AI Holdings Inc. Warrants | $2.04M | — | $0.13 | ▲ 25.85% | $0.0751$0.6488 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Institutional Ownership
March 31, 2026
- Total shares held
- 2.23M
- Total value held
- $691.1K
- Institutional holders
- 8
Top holders this quarter
- Unknown750.0K
- Unknown500.0K
- Unknown456.6K
- Unknown186.6K
- Unknown168.9K
- Unknown90.0K
- Unknown65.9K
- Unknown11.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
BIVIW Featured on Bloomberg TV Show and Gapping on Wednesday
BioVie’s warrant was highlighted on Bloomberg Television’s new show, drawing attention to the company. The same day, BIVIW was listed among the stocks that opened with a gap. The move comes while the price sits near the middle of its 52‑week range. The coverage may increase interest from traders watching the market.
BIVIW Featured on Bloomberg TV Show and Gapping on Wednesday. BioVie’s warrant was highlighted on Bloomberg Television’s new show, drawing attention to the company. The same day, BIVIW was listed among the stocks that opened with a gap. The move comes while the price sits near the middle of its 52‑week range. The coverage may increase interest from traders watching the market.